Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis.
Cathepsin C
cysteine cathepsin
zymogen
zymogen processing
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Sep 2019
25 Sep 2019
Historique:
received:
19
08
2019
revised:
11
09
2019
accepted:
18
09
2019
entrez:
28
9
2019
pubmed:
29
9
2019
medline:
12
2
2020
Statut:
epublish
Résumé
Cysteine cathepsin C (CatC) is a ubiquitously expressed, lysosomal aminopeptidase involved in the activation of zymogens of immune-cell-associated serine proteinases (elastase, cathepsin G, proteinase 3, neutrophil serine proteinase 4, lymphocyte granzymes, and mast cell chymases). CatC is first synthetized as an inactive zymogen containing an intramolecular chain propeptide, the dimeric form of which is processed into the mature tetrameric form by proteolytic cleavages. A molecular modeling analysis of proCatC indicated that its propeptide displayed a similar fold to those of other lysosomal cysteine cathepsins, and could be involved in dimer formation. Our in vitro experiments revealed that human proCatC was processed and activated by CatF, CatK, and CatV in two consecutive steps of maturation, as reported for CatL and CatS previously. The unique positioning of the propeptide domains in the proCatC dimer complex allows this order of cleavages to be understood. The missense mutation Leu172Pro within the propeptide region associated with the Papillon-Lefèvre and Haim-Munk syndrome altered the proform stability as well as the maturation of the recombinant Leu172Pro proform.
Identifiants
pubmed: 31557781
pii: ijms20194747
doi: 10.3390/ijms20194747
pmc: PMC6801622
pii:
doi:
Substances chimiques
Enzyme Precursors
0
Recombinant Proteins
0
Cathepsin C
EC 3.4.14.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Mol Biol. 2002 Sep 20;322(3):559-68
pubmed: 12225749
Semin Immunopathol. 2013 Jul;35(4):411-21
pubmed: 23385856
Protein Expr Purif. 2019 May;157:21-27
pubmed: 30703555
Nat Genet. 1999 Dec;23(4):421-4
pubmed: 10581027
Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
Bioorg Med Chem Lett. 2009 Sep 15;19(18):5392-6
pubmed: 19665376
Biomol Concepts. 2013 Jun;4(3):287-308
pubmed: 25436581
J Biol Chem. 2018 Aug 10;293(32):12415-12428
pubmed: 29925593
Protein Sci. 1999 Feb;8(2):283-90
pubmed: 10048321
Science. 2013 Jan 11;339(6116):227-230
pubmed: 23196907
FEBS J. 2016 Feb;283(3):498-509
pubmed: 26607765
J Immunol. 2013 Sep 1;191(5):2700-7
pubmed: 23904161
Br J Dermatol. 2005 Feb;152(2):353-6
pubmed: 15727652
Biol Chem. 2003 Jun;384(6):837-43
pubmed: 12887050
Acta Biochim Pol. 2015;62(3):629-31
pubmed: 26317128
ACS Med Chem Lett. 2010 Nov 10;2(2):142-7
pubmed: 24900293
Bioinformatics. 2011 Jun 1;27(11):1575-7
pubmed: 21471012
J Immunol. 2004 Dec 15;173(12):7277-81
pubmed: 15585850
J Clin Invest. 2002 Feb;109(3):363-71
pubmed: 11827996
J Clin Invest. 2014 Oct;124(10):4539-48
pubmed: 25244098
Biochemistry. 2001 Feb 13;40(6):1671-8
pubmed: 11327826
Trends Pharmacol Sci. 2017 Oct;38(10):873-898
pubmed: 28668224
J Chem Theory Comput. 2010 Mar 9;6(3):890-909
pubmed: 20305729
J Med Genet. 1999 Dec;36(12):881-7
pubmed: 10593994
J Biol Chem. 2016 Apr 15;291(16):8486-99
pubmed: 26884336
Biol Chem. 2006 Aug;387(8):1143-6
pubmed: 16895486
Pharmacol Rev. 2010 Dec;62(4):726-59
pubmed: 21079042
Pharmacol Ther. 2018 Oct;190:202-236
pubmed: 29842917
EMBO J. 2001 Dec 3;20(23):6570-82
pubmed: 11726493
EMBO J. 1996 Oct 15;15(20):5492-503
pubmed: 8896443
J Biol Chem. 1998 Nov 27;273(48):32000-8
pubmed: 9822672
Mol Genet Genomic Med. 2014 May;2(3):217-28
pubmed: 24936511
J Med Genet. 2000 Feb;37(2):88-94
pubmed: 10662807
J Periodontol. 2002 Mar;73(3):307-312
pubmed: 29539009